Search Results 931-940 of 16681 for crohn's disease

  1. Gastroenterology and Hepatology - Clinical trials

    The aim of this study is to test the validity of the current question database in a large cohort of children with Inflammatory Bowel Disease (IBD) in several ...

  2. Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD

    Approved in 1998 for use in treating Crohn's disease and subsequently in ... inflammatory bowel disease (IBD) symptoms. Unfortunately, about a third of ...

  3. Abdominal pain - Causes and definition - Mayo Clinic

    Cancer · Crohn's disease · Enlarged spleen (splenomegaly) · Gallbladder cancer; Hepatitis (which is inflammation of the liver) ...

  4. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease ... and stage of disease, and previous ...

  5. How to read colonoscopy results

    The exam may show changes that suggest inflammatory bowel diseases such as Crohn's disease or ulcerative colitis. Colonoscopy allows doctors to view ...

  6. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    Long-lasting diarrhea and belly pain could be caused by inflammatory bowel disease, also called IBD. Learn about IBD causes, diagnosis and treatment.

  7. Another Promising Application for Stem Cells: Crohn’s Complications / Date: May 2016 Intro

    Intro: New research at Mayo Clinic is bringing hope to hundreds of thousands of Crohn's disease patients. Their extreme pain from complications is both physical ...

  8. A Study To Evaluate The Effectiveness, Safety And Movement Of Ustekinumab In Pediatric Patients With Moderate-to-Severe, Active Crohn's Disease - Mayo Clinic

    A Study To Evaluate The Effectiveness, Safety And Movement Of Ustekinumab In Pediatric Patients With Moderate-to-Severe, Active Crohn's Disease. Print details.

  9. A Study Of Oral Ozanimod As Induction Therapy For Moderately To Severely Active Crohn's Disease - Mayo Clinic

    The purpose of this study is to explore the effect of oral ozanimod as an induction treatment for subjects with moderately to severely active Crohn's Disease.

  10. Christina Y. Ha, M.D. - Mayo Clinic Faculty Profiles

    Ha, M.D., specializes in the diagnosis and treatment of the inflammatory bowel diseases (IBD) Crohn's disease and ulcerative colitis. Her IBD clinical care ...